Magnesium Sulfate Aurum Pharmaceuticals

Magnesium sulfate, the active ingredient in Magnesium Sulfate Aurum Pharmaceuticals, is an electrolyte presented as an injectable solution for intramuscular and intravenous use. It is employed to correct severe magnesium deficiency and to manage obstetric and cardiac emergencies where rapid magnesium repletion is required. GNH USA supplies Magnesium Sulfate Aurum Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate is used in clinical situations that involve electrolyte imbalance or neuromuscular hyperexcitability. - Severe hypomagnesemia: restores serum magnesium levels to prevent cardiac arrhythmias and neuromuscular irritability. - Eclampsia and pre‑eclampsia: reduces seizure risk by stabilising neuronal excitability in pregnant patients. - Torsades de pointes: shortens QT interval and helps terminate this ventricular tachyarrhythmia. - Preterm labor (tocolysis): relaxes uterine smooth muscle to delay premature contractions.

Adverse reactions may vary with dose and route of administration.

Common Side Effects: - Flushing or feeling of warmth - Nausea or vomiting - Headache - Dizziness or light‑headedness

Serious or Rare Side Effects: - Hypotension or cardiovascular collapse - Respiratory depression, especially with rapid IV administration - Severe allergic reaction (anaphylaxis) - Hypermagnesemia leading to muscle weakness, arrhythmias, or cardiac arrest

Magnesium sulfate requires careful monitoring in several clinical situations. - Renal impairment: monitor serum magnesium and adjust dose to avoid accumulation. - Cardiac disease: use cautiously in patients with conduction abnormalities or heart block. - Pregnancy: assess benefit‑risk ratio, especially in the third trimester. - Concomitant medications: review for agents that may potentiate neuromuscular blockade or affect magnesium levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can alter the activity of several drugs; interactions are classified by clinical significance.

Major Interactions (Avoid): - Neuromuscular blocking agents: potentiation of muscle relaxation. - Calcium channel blockers: additive hypotensive effect. - Aminoglycoside antibiotics: increased risk of neurotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase renal magnesium loss. - ACE inhibitors or ARBs: can raise serum magnesium levels. - Digoxin: magnesium levels influence digoxin toxicity risk.